Daiwa Securities Group’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$413K Sell
4,793
-662
-12% -$59.5K ﹤0.01% 989
2026
Q2
$521K Buy
5,455
+1,516
+38% +$138K ﹤0.01% 961
2026
Q1
$379K Sell
3,939
-300
-7% -$30K ﹤0.01% 953
2025
Q4
$412K Buy
+4,239
New +$364K ﹤0.01% 928

Other funds holding IRMD

Daiwa Securities Group's IRMD Position: Q3 2026 in Review

Daiwa Securities Group reduced its iRadimed (IRMD) stake by 12% in Q3 2026, selling an estimated $59.5K and leaving 4,793 shares worth $413K. The position accounts for ﹤0.01% of the portfolio, ranked #989.

Daiwa Securities Group first reported a position in IRMD in Q4 2025 and has held it in 4 quarters since. The position peaked at $521K in Q2 2026. 215 funds tracked by Wall St. Rank hold IRMD as of Q3 2026.

  • Daiwa Securities Group held 4,793 shares of iRadimed worth $413K as of Q3 2026.
  • Daiwa Securities Group sold 662 iRadimed shares in Q3 2026, an estimated $59.5K.
  • iRadimed made up ﹤0.01% of Daiwa Securities Group's portfolio in Q3 2026, its #989 holding.
  • Daiwa Securities Group first reported a position in iRadimed in Q4 2025 and has held it in 4 quarters since.
  • Daiwa Securities Group's iRadimed position peaked at $521K in Q2 2026.
  • 215 funds tracked by Wall St. Rank held iRadimed as of Q3 2026.

Based on Daiwa Securities Group's 13F filing for Q3 2026, filed 29 Oct 2026.